Pfizer
Pfizer sees robust COVID-19 vaccine demand for years, $26 bln in 2021 sales
Pfizer Inc raised its forecast for 2021 COVID-19 vaccine sales by more than 70% to $26 billion and said demand from governments…
South Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shot
One dose of COVID-19 vaccines from AstraZeneca Plc and Pfizer was 86.6% effective in preventing infections among people aged 60 and older,…
Risk from virus variants remains after first Pfizer COVID-19 vaccine, UK study finds
LONDON, April 30 (Reuters) - A single dose of Pfizer's coronavirus vaccine may not generate a sufficient immune response to protect against…
Pfizer begins exporting U.S.-made COVID-19 vaccine to Mexico
Pfizer Inc’s shipment of COVID-19 vaccine to Mexico this week includes doses made in its U.S. plant, the first of what are…
BioNTech and Pfizer expect vaccine tests on babies by end of Summer
BioNTech expects results by September from trials testing the COVID-19 vaccine that it and Pfizer have developed in babies as young as…
Israel examining heart inflammation cases in people who received Pfizer COVID shot
JERUSALEM, April 25 (Reuters) - Israel's Health Ministry said on Sunday it is examining a small number of cases of heartinflammation in…
UPDATE: Further easing of Covid-19 restrictions in Malta announced / News Briefing – Sunday 25 April 2021
Update - Covid19 Update A 67-year-old person died while diagnosed with Covid. Meanwhile there were 25 new Covid-19 cases registered in the…
EU approves ramp-up of Pfizer vaccine manufacturing site in Belgium
Europe's drug regulator on Friday approved an expansion in manufacturing capacity of the Pfizer/BioNtech COVID-19 vaccine in Belgium, while recommending an approval…
UK vaccination studies find significant drop in COVID-19 infections
COVID-19 infections in adults of all ages fell by 65% after a first dose of AstraZeneca or Pfizer vaccine in UK research,…
EU seals deal with Pfizer-BioNTech for up to 1.8 bln doses of vaccine – EU official
PUURS, Belgium, April 23 (Reuters) - The European Union has sealed the world's biggest vaccine supply deal, agreeing to buy up to…
Pfizer COVID-19 shot effective for people with chronic diseases- Israel study
The COVID-19 vaccine developed by Pfizer and BioNTech is effective at preventing symptomatic and severe disease in people with some chronic illnesses,…
EU secures additional 100 mln COVID-19 doses from Pfizer/BioNTech
The European Union has exercised an option to acquire an additional 100 million doses of BioNTech and Pfizer's COVID-19 vaccine, the two…